tbuckley/cabot-search huggingface dataset:
Prognostic Impact of CD20 and CD25 Expression in Patients with Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL).
Authors: Fabio P.S. Santos, Susan O'Brien, Deborah A. Thomas, Jorge Cortes, Stefan Faderl, Jeffrey L. Jorgensen, Rebecca Garris, Charles Koller, Partow Kebriaei, Alessandra Ferrajoli, Hagop Kantarjian, Farhad Ravandi
Journal: Blood (2009)
A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.
Authors: M.V. Mateos, Joan Blade, J. Diaz Mediavilla, J.J. Lahuerta, M.J. Terol, J. Hernández, M.J. Moro, J. Bargay, J.M. Ribera, J. de la Rubia, A. Sureda, D. Carrera, F. de Arriba, L. Palomera, M. Hernández, J. García Laraña, A. Alegre, F. Prosper, P. Rivas, D.L. Esseltine, D. Schenkein, J.F. San Miguel
Journal: Blood (2004)
Biological treatment is approved for severe eosinophilic asthma
Authors: Susan Mayor
Journal: BMJ (2016)

Draft guidance from the National Institute for Health and Care Excellence (NICE) recommends the monoclonal antibody mepolizumab as an option to treat adult patients with severe refractory asthma and raised eosinophil levels.1

The decision follows an agreement by the manufacturer, GlaxoSmithKline (GSK), to reduce the price of the drug—which has a list price of £840 (€992; $1046) for a once monthly dose—to a lower, but undisclosed, cost to the NHS.

Mepolizumab is a humanised monoclonal antibody that binds to interleukin …
Retrospective Study on 46 Chinese Children with Acute Promyelocytic Leukemia: A Single Center Experience in China.
Authors: Yongmin Tang, Xiaojun Xu, Chan Liao, Limin Zou, Hua Song, Shuwen Shi, Shilong Yang, Jian Wei, Weiqun Xu, Binghua Pan, Yinghu Chen, Fenying Zhao, Hongqiang Shen, Baiqin Qian, Linyan Zhang, Botao Ning
Journal: Blood (2006)
Genetic and Epigenetic Alterations of Ph-Negative Myeloproliferative Neoplasms
Authors: Lyubov Polushkina, Irina Martynkevich, Vasily Shuvaev, Ekaterina Petrova, Lyudmila Martynenko, Natalya Cybakova, Marina Ivanova, Elizaveta Kleina, Elena Shabanova, Dzhariyat Shikhbabaeva, Tatyana Zamotina, Mikhail Fominykh, Kudrat Abdulkadyrov
Journal: Blood (2014)
Immature T-Cell Populations in Lymph Nodes of Castleman Disease and Angioimmunoblastic T-Cell Lymphoma Suggest Alternate Sites of T-Cell Development,
Authors: Robert S. Ohgami, Shuchun Chun, Jane Ohgami, James L. Zehnder, Matthew Van de Rijn, Daniel A. Arber, Yasodha Natkunam, Roger Warnke
Journal: Blood (2011)
Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.
Authors: Anjali Advani, Holly Gundacker, Olga Sala-Torra, Jerald Radich, Raymond Lai, Marilyn L. Slovak, Jeffrey E Lancet, Steve Coutre, Robert K Stuart, Martha P. Mims, Patrick Stiff, Frederick R. Appelbaum
Journal: Blood (2009)
Neuroendocrine-immune response and mood changes in early breast cancer patients following surgery and adjuvant chemotherapy
Authors: P. Pugliese, A. Fabi, A. Bonucci, S. Capoccia, A. Berry, C. Raggi, M. Vomero, E. Ortona, F. Cognetti, F. Cirulli
Journal: Annals of Oncology (2015)
Reciprocal Interaction between NPM Leukemic Mutants and Arf: Structural Basis and Functional Consequences.
Authors: Niccolo’ Bolli, Maria Paola Martelli, Barbara Bigerna, Alessandra Pucciarini, Barbara Verducci, Teresa Pallotta, Felicetta de Marco, Valentina Pettirossi, Roberta Mannucci, Elisabetta Bonifacio, Antonio Tabilio, Ildo Nicoletti, Brunangelo Falini
Journal: Blood (2006)
A painful tingling hand
Authors: Claire Burton, Linda S Chesterton, Graham Davenport
Journal: BMJ (2016)

This is part of a series of occasional articles on common problems in primary care. The BMJ welcomes contributions from GPs.

#### What you need to know

A 48 year old woman presents with pain and tingling in the thumb, index, and middle finger of her left hand. Her symptoms are worse at night and wake her from sleep. Shaking her hands relieves the discomfort.

Pain, numbness, and tingling in the hands are common, with a population prevalence of 14.4%.1 The most common entrapment neuropathy and most likely diagnosis is carpal tunnel syndrome.2 The incidence of carpal tunnel syndrome is 192.8 per 100 000 in women and 87.8 per 100 000 in men.3

Consider the patient’s symptoms anatomically. Figure 1⇓ shows the sensory innervation of the hand.



Fig 1  Sensory innervation of the hand

©Keele University 2013

### Causes of pain and numbness in the hand

#### Median nerve compression

Compression of the median nerve in the carpal tunnel gives rise to sensory dysfunction. Patients might describe numbness, tingling, pain, or aching of the thumb, index, middle finger, and radial half of the ring finger. Aching often extends to the elbow. Motor deficit includes weakness in flexion of the index and middle finger and weakness in thumb abduction and opposition.4 5 Carpal tunnel syndrome affects women more than men at a ratio of …
Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia
Authors: George G. Zhanel, Erika Hartel, Heather Adam, Sheryl Zelenitsky, Michael A. Zhanel, Alyssa Golden, Frank Schweizer, Bala Gorityala, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Alfred S. Gin, Daryl J. Hoban, Joseph P. Lynch, James A. Karlowsky
Journal: Drugs (2016)
The Gene Locus Distribution of HLA in the Chinese Population by High Resolution Typing of HLA-A,B,C,DR,DQ and Its Effect on Stem Cell Transplantation.
Authors: Jian Q. Hou, Jun He, Zi X. Chen, Xiao J. Bao, Li Yao, Wen Y. Di, Hui Zhang, Jian Zhang
Journal: Blood (2006)
Low VWF:RCo In Subjects with VWF Polymorphisms D1472H and P1467S Due to Decreased Binding of Ristocetin to the VWF A1 Domain
Authors: Veronica H Flood, Jeffrey S Wren, Sandra L Haberichter, Kenneth D Friedman, Daniel B. Bellissimo, Joan Cox Gill, Raymond G Hoffmann, J. Paul Scott, Robert R Montgomery
Journal: Blood (2010)
Activation Levels of Natural Killer Cells and CD8+ T Cells Correlate Highly with Sustained Complete Molecular Response After Discontinuation of Imatinib in Chronic Myeloid Leukemia Patients
Authors: Seiichiro Katagiri, Izuru Mizoguchi, Takayuki Yoshimoto, Junichiro Mizuguchi, Junko H Ohyashiki, Kazuma Ohyashiki
Journal: Blood (2012)
Serial Plasma Concentrations of Adipocytokines during Chemotherapy in Children with Acute Lymphoblastic Leukemia
Authors: Maria M Moschovi, Georgios G Trimis, Maria M Vounatsou, Katerina K Katsibardi, Alexandra A Margeli, Andreas A Damianos, George G Chrousos, Fotini F Tzortzatou-Stathopoulou, Ioannis I Papassotiriou
Journal: Blood (2008)
The Transcriptional Coactivator Bob1 Is Associated With Pathologic B Cell Responses in Autoimmune Tissue Inflammation
Authors: Maria J. Levels, Melissa N. Van Tok, Tineke Cantaert, Juan D. Cañete, Frans G. M. Kroese, Kristine Germar, Hergen Spits, Dominique L. P. Baeten, Nataliya G. Yeremenko
Journal: Arthritis & Rheumatology (2016)

The molecular mechanisms steering abnormal B cell responses in autoimmune diseases remain poorly understood. We undertook this study to identify molecular switches controlling pathologic B cell responses in rheumatoid arthritis (RA).Candidate molecules were identified by gene expression profiling of RA synovitis and validated by quantitative polymerase chain reaction and immunohistochemistry. B cell-specific expression was confirmed by immunofluorescence, immunoblotting, and flow cytometry. The role of Bob1 in pathologic B cell responses was assessed in collagen-induced arthritis (CIA).Transcriptional profiling of RA synovitis revealed a prominent B cell signature, with the transcriptional coactivator Bob1 and its putative target BCMA being among the most up-regulated genes. Further analysis confirmed the microarray data and demonstrated elevated levels of Bob1 in B cells in RA synovium. A functional study showed that Bob1-deficient mice failed to produce pathogenic anti-type II collagen (anti-CII) antibodies and were resistant to CIA. Adoptive transfer of cells from Bob1-deficient and Bob1-sufficient mice to recombination-activating gene 1-null mice demonstrated that Bob1 deficiency exclusively in B cells abrogated germinal center (GC) B cell formation, anti-CII antibody production, and CIA development. Consistent with data from animal studies, immunophenotyping of human B cell subsets revealed increased expression of Bob1, predominantly in centrocytes and centroblasts. Correspondingly, Bob1 expression in RA synovitis was strongly correlated with CD21L, a molecular marker of GCs. In addition, similar Bob1 overexpression and correlation with CD21L expression was evidenced in parotid salivary gland tissue from patients with primary Sjögren's syndrome.These expression and functional data identify the transcriptional coactivator Bob1 as a candidate molecular switch of pathogenic B cell responses in autoimmune diseases in humans.
Therapeutic Plasma Exchange for the Treatment of Thrombotic Microangiopathy without Severe ADAMTS13 Deficiency: A Propensity Score-Matched Study
Authors: Ang Li, Robert S Makar, Shelley Hurwitz, Lynne Uhl, Richard M. Kaufman, Christopher P. Stowell, Walter Dzik, Pavan Bendapudi
Journal: Blood (2015)
SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML
Authors: May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey, Patrick J. Burke, Changpu Yu, Kimberly H. Harrington, Ivan Stone, Maureen C. Ryan, Django Sussman, Weiping Zeng, Dennis R. Benjamin, Irwin D. Bernstein, Peter D. Senter, Jonathan G. Drachman, Julie A. McEarchern
Journal: Blood (2012)
Quantitative RT-PCR for Expression of a Small Subset of Genes Identifies Novel Prognostic Subgroups in High-Risk Pediatric Precursor B-Cell Acute Lymphoblastic Leukemia (HR-ALL): Clinical Applicability of Gene Expression Microarray Data from Children’s Oncology Group Trials.
Authors: David R. Czuchlewski, Richard C. Harvey, I-Ming Chen, Ali Bourguet-Vincent, Bradley Rodgers, Richard Vestal, Kerem Ar, Huining Kang, Carla S. Wilson, Eric C. Larsen, Stephen P. Hunger, Mignon Loh, Meenakshi Devidas, Elizabeth Raetz, Gregory Reaman, William L. Carroll, Naomi Winick, Cheryl L. Willman
Journal: Blood (2008)
Debated Role of Ovarian Protection With Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Women With Cancer
Authors: Matteo Lambertini, Tommaso Falcone, Joseph M. Unger, Kelly-Anne Phillips, Lucia Del Mastro, Halle C.F. Moore
Journal: Journal of Clinical Oncology (2017)
European reference networks: moving towards a tangible outcome of the European Union's cross-border healthcare directive?
Authors: Nadia Kamel
Journal: European Respiratory Journal (2016)

October 25, 2013 was the deadline for all European Union (EU) countries to transpose the directive on patients' rights in cross-border healthcare, adopted in March 2011, into their national law [1]. The ability of patients and health professionals to move across borders within the EU flows directly from the fundamental freedoms of movement of people and services [2]. European Reference Networks is an EU cross border healthcare initiative for improving lives of rare disease patients <http://ow.ly/FXmg304q5BR>
Six Month Treatment of Low Dose Eltrombopag Is Efficacious in Japanese Patients with Refractory Chronic Immune Thrombocytopenic Purpura (ITP).
Authors: Yoshiaki Tomiyama, Yoshitaka Miyakawa, Shinichiro Okamoto, Shinya Katsutani, Akiro Kimura, Yasushi Okoshi, Haruhiko Ninomiya, Hiroshi Kosugi, Shosaku Nomura, Katsutoshi Ozaki, Yasuo Ikeda, Nobuyuki Koh, Koichi Katsura, Yuzuru Kanakura
Journal: Blood (2009)
Identification of Venous Thromboembolism (VTE)-Associated Novel Variants in the ABO Gene Using Targeted Deep Sequencing
Authors: Yan W. Asmann, Mariza de Andrade, Sumit Middha, Martha E. Matsumoto, Sebastian M. Armasu, Tanya M. Petterson, Julie M. Cunningham, John A. Heit
Journal: Blood (2011)
Up-Regulation of Flt3 Is a Passive Event in Hoxa9/Meis1-Induced Acute Myeloid Leukemia
Authors: Anna Staffas, Yuan Wei, Laleh Arabanian, Ann Jansson, Sara Ståhlman, Susanne Li, Linda Fogelstrand, Jörg Cammenga, Florian Kuchenbauer, Lars Palmqvist
Journal: Blood (2015)
Comparison of Cord Blood Transplant Outcome between U.S. Versus Non-U.S. Transplant Centers for Cord Blood from a Single Source.
Authors: Brian Wang, Peggy Tseng, Tina Wu, Joseph Rosenthal, Tang-Her Jaing, Lee Lee Chan, Ah Moy Tan, Poh-Lin Tan, Hai-Peng Lin, Allen Lin, Steven Yang, Tiffany Chow, David Gjertson, Lawrence Petz, Patrick Tan, Robert Chow
Journal: Blood (2006)
Abstract 16178: Myeloperoxidase in Pericardial Drainage is a More Specific Predictor of Atrial Fibrillation in Patients Following Isolated Coronary Artery Bypass Grafting
Authors: Li Sun, Fangqin Wu, Ying Wu, Pixiong Su, Ling Wang, Meng Yu, Haibo Zhao, Haiyong Zhang
Journal: Circulation (2013)

Purpose: Evidence shows that systemically and locally increased myeloperoxidase (MPO) availability is associated with AF, while their roles and predictive values on the occurrence of AF after CABG ...
Comparison of Post-Transplant Outcomes in Non-Hodgkin Lymphoma (NHL) Patients Mobilized with or without Plerixafor Added to Chemomobilization
Authors: Ville Varmavuo, Johanna Rimpiläinen, Anne Nihtinen, Kaija Vasala, Maija Mikkola, Päivi Lehtonen, Taru Kuittinen, Pentti Mäntymaa, Tapio Nousiainen, Outi Kuittinen, Esa Jantunen
Journal: Blood (2012)
Abstract 15921: Antihypertensive Effects of Minocycline Are Associated With Improvement of Inflammatory Status in Patients With Treatment Resistant Hypertension
Authors: YanFei Qi, Seungbum Kim, Dana D Leach, Sarah J Long, Eileen M Handberg, Vermali Rodriguez, Avinash Mandloi, Mohan K Raizada, Carl J Pepine
Journal: Circulation (2016)

Background: Treatment resistant hypertension (TRH) is present in ~15% of hypertensive patients. It markedly increases mortality risk. Based on our previous studies and evidence from literature, we ...
The Novel Proteasome Inhibitor Carfilzomib (CFZ) Potentiates the Anti-Tumor Activity of Chemotherapeutic Agents in Rituximab-Chemotherapy Resistant Lymphoma Through Inducing G2/M Cell Cycle Arrest and Cell Death
Authors: Juan Gu, Natalie M Czuczman, Gregory P. Kaufman, Cory Mavis, Francisco J. Hernandez-Ilizaliturri, Myron S. Czuczman
Journal: Blood (2011)
Protein Disulfide Isomerase Inhibitors: A New Class of Antithrombotic Agents
Authors: Reema Jasuja, Freda H. Passam, Daniel R Kennedy, Sarah H Kim, Lotte van Hessem, Lin Lin, Sucharit S Joshi, James R. Dilks, Bruce Furie, Barbara C. Furie, Robert C. Flaumenhaft
Journal: Blood (2011)
Indoleamine 2,3-Dioxygenase-1 (IDO1) Is Expressed by a Subset of Childhood Acute Myeloid Leukemias and Restrains IFN-γ Production by T Cells
Authors: Valentina Folgiero, Daniela Natale, Daria Pagliara, Roberta Caruso, Luciana Vinti, Valentina Coletti, Francesca Moretta, Raimondo De Cristofaro, Franco Locatelli, Sergio Rutella
Journal: Blood (2012)
CALM-AF10 and HOX11L2 Abnormalities Define Poor Prognostic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia.
Authors: Martine van Grotel, Jules P.P. Meijerink, Max M. van Noesel, H. Berna Beverloo, Anton W. Langerak, Tim S. Poulsen, Elisabeth R. van Wering, E. Gritta Janka-Schaub, Rob Pieters
Journal: Blood (2005)
Severe Fetal and Neonatal Anemia Due to Heterozygosity for a 198 Kb Deletion Removing the Entire β-Globin Gene Cluster
Authors: Madeleine Verhovsek, Nirmish Shah, Courtney Thornburg, Sara Koenig, Ibifiri Wilcox, Tiago Barros, Martin H. Steinberg, Hong Luo, David H.K. Chui
Journal: Blood (2010)
Common Gene Expression Changes in Matched Pretreatment and Relapse Samples from Eastern Cooperative Oncology Group Acute Promyelocytic Leukemia (APL) Patients Treated on the Chemotherapy (C) or All-Trans Retinoic Acid (ATRA)-Containing (A) Randomization Arms of Protocol E2491.
Authors: Qingping Cui, Haesook Kim, Peter H. Wiernik, Martin S. Tallman, Robert E. Gallagher
Journal: Blood (2006)
Discovery of Growth Differentiation Factor 15 as an Erythroblast-Secreted Regulator of Hepcidin with Very High Level Expression in Patients with Thalassemia.
Authors: Toshihiko Tanno, Natarajan V. Bhanu, Patricia A. Oneal, Sung-Ho Goh, Pamela Staker, Y. Terry Lee, Naomi L.C. Luban, Richard Childs, Susan F. Leitman, Jeffery L. Miller
Journal: Blood (2006)
Continuous Intravenous Injection of Mesna Is Powerful in Preventing Acute Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation: 108 Cases report
Authors: Qian-li Jiang, Qi-Fa Liu, Jing SUN, Zhiping Fan, Hongsheng Zhou, Yang Zhang, Yan-yan Chai, Dan Xu, Qi Wei, Guo-pan Yu, Jie Zhao, Xiao-fang Li, Guan-nan Yu, Qin Huang, Fan-Yi Meng
Journal: Blood (2011)
Evidence for Killing of Mesenchymal Stem Cells (MSC) by Autologous Natural Killer Lymphocytes.
Authors: Alessandro Poggi, Anna-Maria Massaro, Simone Negrini, Ivana Pierri, Manuela Balocco, Gianluca Michelis, Sara Aquino, Alessandra Albarello, Marco Gobbi, Maria Raffaella Zocchi
Journal: Blood (2004)
Stem Cell Transplantation with 90yttrium Ibritumomab Tiuxetan(90YIT) in Non-Hodgkin's Lymphoma (NHL): Observations From PET Pre-Treatment Imaging and Responses in Allografted Refractory Follicular Histologies.
Authors: Issa F Khouri, Robyn Harrell, Rosamar Valverde, Martin Korbling, Taghi Manshouri, Barry Samuels, Farzaneh Maadani, Grace-Julia Okoroji, Roland L Bassett, Alousi Amin, Paolo Anderlini, Marcos De Lima, Sergio Giralt, Chitra Hosing, Partow Kebriaei, Uday Popat, Muzaffar Qazilbash, Naoto Ueno, Anne Marie Stachowiak, Bill Erwin, Luis Fayad, Barbara Pro, Nathan Fowler, Peter McLaughlin, Sattva Neelapu, Anas Younes, Richard Champlin, Donald Podoloff
Journal: Blood (2009)
Role of Extracellular Signal-Regulated Kinase-1/2 (ERK) on Complete Remission Achievement of Primary Adult Acute Lymphoblastic Leukemia Patients Enrolled in the GIMEMA Protocol LAL 2000: In Vitro Activity of the MEK Inhibithor PD98059.
Authors: Chiara Gregorj, Maria T. Petrucci, Maria C. Scerpa, Maria R. Ricciardi, Fabiana De Cave, Jacopo Gervasoni, Marco Vignetti, Stefania Gubbiotti, Cristina Ariola, Giorgina Specchia, Annalisa Chiarenza, Felicetto Ferrara, Francesco Fabbiano, Andrea Camera, Giuseppe Fioritoni, Eustachio Miraglia, Luciana Annino, Federico Mosna, Nicola Cantore, Mario Luppi, Francesco Nobile, Giuseppe Leone, Lorella Depaoli, Antonio Peta, Massimo A. Martelli, Ignazio Majolino, Marco Montanaro, Michele Milella, Giovanna Meloni, Robert Foà, Agostino Tafuri
Journal: Blood (2005)
Vedolizumab as a successful treatment of CTLA-4–associated autoimmune enterocolitis
Authors: Alexander A. Navarini, Petr Hruz, Christoph T. Berger, Tie Zheng Hou, Charlotte Schwab, Annemarie Gabrysch, Rebecca Higgins, Natalie Frede, Barbara-Christina Padberg Sgier, Olle Kämpe, Anne-Valérie Burgener, Florian Marquardsen, Fabian Baldin, Marc Bigler, Anne Kistner, Annaise Jauch, Olivier Bignucolo, Benedikt Meyer, Fabian Meienberg, Matthias Mehling, Lukas T. Jeker, Ingmar Heijnen, Thomas D. Daikeler, Jan-Olaf Gebbers, Bodo Grimbacher, David M. Sansom, Raphael Jeker, Christoph Hess, Mike Recher
Journal: Journal of Allergy and Clinical Immunology (2016)
Dorsal column myelopathy after intrathecal chemotherapy for leukemia
Authors: Chelsea C. Pinnix, Linda Chi, Elias J. Jabbour, Sarah A. Milgrom, Grace L. Smith, Naval Daver, Naveen Garg, Matthew D. Cykowski, Greg Fuller, David Cachia, Carlos Kamiya-Matsuoka, Karin Woodman, Courtney Dinardo, Nitin Jain, Tapan M. Kadia, Naveen Pemmaraju, Maro Ohanian, Marina Konopleva, Hagop M. Kantarjian, Bouthaina S. Dabaja
Journal: American Journal of Hematology (2016)

Intrathecal chemotherapy with methotrexate, a folate antagonist, is widely used to treat central nervous system malignancies. The mechanisms underlying methotrexate-induced neurotoxicity are unclear but may be related to increased homocysteine levels. Intrathecal methotrexate-induced myelopathy mimicking subacute combined degeneration, with normal B12 levels, has been documented. We examined treatment and magnetic resonance imaging (MRI) characteristics of 13 patients with leukemia who received intrathecal methotrexate and developed urinary and bowel incontinence, ascending motor weakness, and sensory loss with dorsal column hyperintensity on MRI between 2000 and 2016. Cerebrospinal fluid evaluation was negative for leukemia in all patients and positive for elevated protein in 12 patients. Seven of eight patients with available data had reduced serum folate, increased serum homocysteine, or both, implicating methotrexate as the cause of neurotoxicity. Autopsy of one patient revealed loss of myelinated axons in the posterior columns. These findings suggest that methotrexate neurotoxicity may be mediated by folate antagonism. Awareness and a high index of suspicion of these characteristic clinical and radiographic features in patients who develop myelopathy after intrathecal methotrexate may help to avoid additional neurotoxic therapy in such patients.
Iron Overload Impairs Hematopoiesis by Damaging MSCs Through ROS Signaling Pathway.
Authors: Wenyi Lu, Mingfeng Zhao, Xiao Chai, Juanxia Meng, Fang Xie, Juan Mu, Haibo Zhu, Xinnv Xu, Xia Xiao, Qi Deng, Li Ma
Journal: Blood (2012)
Older Patients with Normal Cytogenetics AML Have a Higher Rate of Genomic Changes Compared to Young Patients as Determined by SNP Chip Analysis
Authors: Maya koren-Michowitz, Carsten Müller-Tidow, Aiko Matsubara, Stefanie Göllner, Wolfgang E. Berdel, Arnon Nagler, Seishi Ogawa, H. Phillip Koeffler
Journal: Blood (2010)
Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).
Authors: Veronique Leblond, Kamel Laribi, Osman Ilhan, Melih Aktan, Ali Unal, Saad M B Rassam, Anna Schuh, Tom Widenius, Peter Johansson, Joao Raposo, Balkis Meddeb, Carol Moreno, Stephan H.K. Oertel, Anne-Sophie Michallet
Journal: Blood (2012)